The DOI matches its Crossref record.
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
Abstract
Activation of the Fas cell surface molecule, either by specific antibody or by its as yet unidentified ligand, has been shown to induce apoptosis. Because apoptosis is also evoked in target cells by cytolytic T cells, we investigated whether the Fas pathway is involved in CD4+ T cell-mediated cytotoxicity. Analysis of Fas expression in APC, such as the B lymphoma A20.2J and MHC class II-transfected fibroblasts RT2.3, revealed a correlation between the degree of expression and sensitivity to cytotoxic attack, high level of Fas expression in A20.2J being associated with efficient lysis. To examine whether increased Fas expression in RT2.3 would render these cells more susceptible to CD4+ CTL lysis, they were transfected with a Fas gene expression vector. Indeed, Fas- but not mock-transfected RT2.3 proved to be more sensitive to lysis by either Ag specifically or nonspecifically activated CD4+ CTL. Similarly, MHC class II-negative, Fas-transfected L1210 leukemia cells were lysed with nonspecifically activated CD4+ CTL. The importance of the Fas engagement in CD4+ CTL-mediated cytotoxicity is further substantiated by the failure of both cloned and normal CD4+ CTL to lyse B cell blasts from Ipr mice. These mice are known to have a defect in functional Fas expression. Although the bulk of CD4+ T cell-mediated lysis appears to be Fas induced, the fact that the effector phase of A20.2J lysis is only partially Ca2+ independent indicates that other pathways also contribute to target cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M., & Krammer, P. H. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,609
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D. H., Stanger, B. Z., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/373444a0 · Cited by 1,499
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
Fas ligand mediates activation-induced cell death in human T lymphocytes.
Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F., & Lynch, D. H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.71 · Cited by 934
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
Fas and Fas ligand: lpr and gld mutations
Nagata, S., & Suda, T. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80069-7 · Cited by 892
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W.-W., Kruzel, E., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3032 · Cited by 734
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., & Runkel, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1223 · Cited by 692
Expression of the functional soluble form of human fas ligand in activated lymphocytes.
Tanaka, M., Suda, T., Takahashi, T., & Nagata, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07096.x · Cited by 638
Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product
Tewari, M., & Dixit, V. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3255 · Cited by 596
Kägi, D., Ledermann, B., Bürki, K., Zinkernagel, R. M., & Hengartner, H. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.207 · Cited by 588
Zamai, L., Ahmad, M., Bennett, I. M., Azzoni, L., Alnemri, E. S., & Perussia, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2375 · Cited by 566
Fas and FasL in the homeostatic regulation of immune responses
Lynch, D. H., Ramsdell, F., & Alderson, M. R. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80079-4 · Cited by 558
Liles, W. C., Kiener, P. A., Ledbetter, J. A., Aruffo, A., & Klebanoff, S. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.429 · Cited by 557
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Benmebarek, M.-R., Karches, C. H., Cadilha, B. L., Lesch, S., Endres, S., & Kobold, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061283 · Cited by 531
Maciejewski, J., Selleri, C., Anderson, S., & Young, N. (1995) · Blood · doi:10.1182/blood.v85.11.3183.bloodjournal85113183 · Cited by 476
Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells
Rothstein, T. L., Wang, J. K. M., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S.-T., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/374163a0 · Cited by 413
The Significance of Vasoactive Intestinal Peptide in Immunomodulation
Delgado, M., Pozo, D., & Ganea, D. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.7 · Cited by 412
Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
Garrone, P., Neidhardt, E. M., Garcia, E., Galibert, L., van Kooten, C., & Banchereau, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1265 · Cited by 390
Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules
Henkart, P. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90063-9 · Cited by 386
Fas-mediated cytotoxicity by freshly isolated natural killer cells.
Arase, H., Arase, N., & Saito, T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1235 · Cited by 362
The role of CD95 and CD95 ligand in cancer
Peter, M. E., Hadji, A., Murmann, A. E., Brockway, S., Putzbach, W., Pattanayak, A., & Ceppi, P. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.3 · Cited by 357
Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death
D'Souza, S. D., Bonetti, B., Balasingam, V., Cashman, N. R., Barker, P. A., Troutt, A. B., Raine, C. S., & Antel, J. P. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2361 · Cited by 354
Oddo, M., Renno, T., Attinger, A., Bakker, T., MacDonald, H. R., & Meylan, P. R. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5448 · Cited by 345
Thomas, W. D., & Hersey, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2195 · Cited by 326
Qian, S., Lu, L., Fu, F., Li, Y., Li, W., Starzl, T. E., Fung, J. J., & Thomson, A. W. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4654 · Cited by 302
Liou, A. K. F., Clark, R. S., Henshall, D. C., Yin, X.-M., & Chen, J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00005-4 · Cited by 297
Brown, D. M., Dilzer, A. M., Meents, D. L., & Swain, S. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2888 · Cited by 282
The central and multiple roles of B cells in lupus pathogenesis
Chan, O. T. M., Madaio, M. R., Shlomchik, M. J., Chan, O. I. M., Madaio, M. P., & Shlomchik, M. J. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01310.x · Cited by 281
Baker, M. B., Altman, N. H., Podack, E. R., & Levy, R. B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2645 · Cited by 281
Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway
Goillot, E., Raingeaud, J., Ranger, A., Tepper, R. I., Davis, R. J., Harlow, E., & Sanchez, I. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3302 · Cited by 263
Ayala, A., Herdon, C., Lehman, D., Ayala, C., & Chaudry, I. (1996) · Blood · doi:10.1182/blood.v87.10.4261.bloodjournal87104261 · Cited by 258
The Fas counterattack: Cancer as a site of immune privilege
O’Connell, J., Bennett, M. W., O’Sullivan, G. C., Collins, J. K., & Shanahan, F. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01382-6 · Cited by 232
Metadata
- Authors
- Stalder, T., Hahn, S., & Erb, P.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-02-01
- Volume
- 152
- Issue
- 3
- Pages
- 1127-1133
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1496938524
- Cited by
- 373
- References
- 0
- FWCI
- 15.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.